RCS - Kanabo Group PLC - Investor Updates

KanaboAnnouncement

11/03/2022 11:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220311:nRSK5196Ea&default-theme=true

RNS Number : 5196E  Kanabo Group PLC  11 March 2022

Kanabo Group Plc

("Kanabo" or the "Company")

 

Investor Updates

 

Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis Company
focussing on the development and distribution of cannabis-derived products for
medical patients and wellness CBD consumers, has posted their latest investor
newsletter and investor presentation to their website.

 

The latest Company presentation can be viewed here;

https://www.kanabogroup.com/wp-content/uploads/2022/03/Kanabo_GP_V01_230222.pdf
(https://www.kanabogroup.com/wp-content/uploads/2022/03/Kanabo_GP_V01_230222.pdf)

 

The Company has also posted a recent webinar with Vox Markets where Kanabo
CEO, Avihu Tamir and GP Service CEO, Atul Devani discuss the GP Services
acquisition. The webinar can be viewed here;

Watch the Kanabo webinar hosted by Vox Markets - Vox Markets
(https://www.voxmarkets.co.uk/media/6217965e2d9e6c23273be2a8/?context=/listings/LON/KNB/)

 

The latest Kanabo Investor Newsletter discussing the significant progress made
over recent months can be viewed here;
https://www.kanabogroup.com/press/foreword-from-the-ceo-march-11-2002/
(https://www.kanabogroup.com/press/foreword-from-the-ceo-march-11-2002/)

 

 

For further information, please visit http://www.kanabogroup.com/ or contact
the following:

 Kanabo Group Plc
 Avihu Tamir, CEO                                       Via Vox Markets
 Peterhouse Capital Ltd
 Eran Zucker (Financial Adviser)                        Tel: +44 (0)20 7469 0930
 Lucy Williams / Charles Goodfellow (Corporate Broker)  Tel: +44 (0)20 7469 0930
 Vox Markets (Investor Relations)
 Kat Perez                                              KanaboGroup@voxmarkets.co.uk

 

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry
to improve the well-being of millions of people around the world by providing
a better alternative to the smoking of medicinal cannabis flowers. Kanabo,
which was the first medicinal cannabis company to IPO on London Stock
Exchange, has a focus on the distribution of cannabis-derived products for
medical patients and non-THC products for CBD consumers. It has conducted
extensive Research & Development to produce high-quality cannabis extract
formulas, innovative medical-grade vaporizers, and various non-smoking
consumption solutions. Kanabo sells a range of medical cannabis products and
wellness CBD products in the Primary Markets, including its VapePod, which
delivers a metered dose with every inhalation.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABKDBBDBKDBND